X4 Pharmaceuticals, Inc — Director's Dealing 2021

Oct 18, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: X4 Pharmaceuticals, Inc (XFOR)
CIK: 0001501697
Period of Report: 2021-10-14

Reporting Person: de Craecker Francoise (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-14	Stock Option (right to buy)	$5.37	A	12250	Acquired	2031-10-13	Common Stock (12250.0)	Direct

Footnotes

F1: 33.3333% of the shares subject to the option shall vest on October 14, 2022, with the remainder vesting thereafter in equal monthly installments of 2.7777% of the shares subject to the option until the 36-month anniversary of the date of the grant, subject to the Reporting Person's continued services as a director through each applicable vesting date.